Welltower Stock Hits 52-Week High on Strong Q2 Revenue Beat

Welltower Inc. (NYSE: WELL) shares jumped 4.3% in after-hours trading on July 27 after the healthcare real estate investment trust (REIT) posted second-quarter revenue that handily beat Wall Street estimates. The strong top-line performance propelled the stock to a new 52-week high, signaling robust investor confidence in the company's growth.

Earnings Beat Overshadows FFO Miss

Welltower reported its second-quarter 2026 results after the market close, revealing key financial metrics that drove the stock's move:

• Revenue: $3.54 billion, a significant outperformance compared to the analyst consensus of $3.36 billion. This figure represents a 39.1% increase from the same period one year prior.
• Normalized Funds From Operations (FFO): $1.60 per diluted share. While this was slightly below the Wall Street estimate of $1.66, investors appeared to focus on the magnitude of the revenue beat.

The stock reached $258.95 in extended trading, surpassing its previous 52-week high of $252.94. The move was company-specific, as the broader S&P 500 index was nearly flat for the day.

Ad

Analyst Confidence and Sector Fundamentals

The positive earnings report was amplified by growing conviction among analysts. On the same day as the release, Mizuho raised its price target on Welltower stock to $260 from a previous $239. This follows an earlier upgrade this month from UBS, which lifted its target to $271.

According to the report, Welltower's seniors housing operating portfolio remains a primary engine for its growth. The company continues to benefit from powerful demographic trends, namely an aging U.S. population, combined with a constrained supply of new properties entering the market. These fundamentals underpin the company's strong revenue growth and positive investor sentiment.